Rockefeller Capital Management’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
Other funds holding RARE
Rockefeller Capital Management's RARE Position: Q3 2026 in Review
Rockefeller Capital Management reduced its Ultragenyx Pharmaceutical (RARE) stake by 45% in Q3 2026, selling an estimated $19.9K and leaving 1,017 shares worth $15.3K. The position accounts for ﹤0.01% of the portfolio, ranked #3993.
Rockefeller Capital Management first reported a position in RARE in Q1 2018 and has held it in 26 quarters since. The position peaked at $560K in Q4 2020. 267 funds tracked by Wall St. Rank hold RARE as of Q3 2026.
- Rockefeller Capital Management held 1,017 shares of Ultragenyx Pharmaceutical worth $15.3K as of Q3 2026.
- Rockefeller Capital Management sold 828 Ultragenyx Pharmaceutical shares in Q3 2026, an estimated $19.9K.
- Ultragenyx Pharmaceutical made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q3 2026, its #3993 holding.
- Rockefeller Capital Management first reported a position in Ultragenyx Pharmaceutical in Q1 2018 and has held it in 26 quarters since.
- Rockefeller Capital Management's Ultragenyx Pharmaceutical position peaked at $560K in Q4 2020.
- 267 funds tracked by Wall St. Rank held Ultragenyx Pharmaceutical as of Q3 2026.
Based on Rockefeller Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.